Acer Therapeutics Inc
ACER
ACER was delisted on the 8th of November, 2023.
37 hedge funds and large institutions have $4.59M invested in Acer Therapeutics Inc in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 12 increasing their positions, 16 reducing their positions, and 4 closing their positions.
8% less funds holding
Funds holding: 40 → 37 (-3)
25% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 16
53% less capital invested
Capital invested by funds: $9.73M → $4.59M (-$5.13M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$92.2K |
| 2 |
State Street
Boston,
Massachusetts
|
+$92.2K |
| 3 |
Bank of New York Mellon
New York
|
+$39.3K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$36.9K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$6.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JGC
J. Goldman & Co
New York
|
-$295K |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$95.3K |
| 3 |
Two Sigma Investments
New York
|
-$84K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$80K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$51.3K |
ACER Hedge Fund Activity: Q1 2020 in Review
37 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q1 2020, worth a combined $4.59M — down 53% from $9.73M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ACER and 1 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 12 added.
The largest buyer was Federated Hermes, adding an estimated $92.2K. The largest seller was J. Goldman & Co, exiting entirely with an estimated $295K sold.
- 37 institutional investors held Acer Therapeutics Inc (ACER) as of Q1 2020, down from 40 in Q4 2019.
- Funds reported $4.59M of Acer Therapeutics Inc stock for Q1 2020, down 53% quarter-over-quarter.
- 1 fund opened new Acer Therapeutics Inc positions in Q1 2020 and 4 closed out, a net change of -3 holders.
- The largest Acer Therapeutics Inc buyer in Q1 2020 was Federated Hermes, an estimated $92.2K added.
- The largest Acer Therapeutics Inc seller in Q1 2020 was J. Goldman & Co, an estimated $295K sold.
Based on aggregated 13F filings for Q1 2020.